Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Clinical trial NCT00980005 · COMPLETED
Trial details
- NCT number
- NCT00980005
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-13
- Primary completion
- 2010-03-02
- Enrollment
- 2116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.